Stick2PrEP Cisgender Women and Trans Individuals

NARecruitingINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

October 25, 2021

Primary Completion Date

October 25, 2026

Study Completion Date

October 25, 2026

Conditions
HIV PreventionPre-exposure Prophylaxis
Interventions
BEHAVIORAL

Individualized Feedback

Participants taking PrEP will receive questionnaires regarding self-reported weekly PrEP adherence; they will then receive individualized text-message or email feedback based on their self-reported adherence.

Trial Locations (1)

10032

RECRUITING

Columbia University Medical Center, New York

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Columbia University

OTHER